CBR Pharma Insights Market Research Reports

Title published price

Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape

By CBR Pharma Insights

Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary GBI Research's latest report "Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory ...

03-Jan-2019 $2995

Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics

By CBR Pharma Insights

Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics Summary GBI Research's latest report: "Biosimilars" provides an in-depth assess ...

01-Jan-2019 $2995

Global Clinical Trials - Current Trends and Recent Advancement

By CBR Pharma Insights

Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research's latest report, Global Clinical Trials - Current Trends and Recent Advancement, provides an in-depth assessment of the current trends in th ...

01-Jan-2019 $2995

Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline

By CBR Pharma Insights

Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research's latest report "Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline" is a comprehensive, granu ...

14-Dec-2018 $2995

Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players

By CBR Pharma Insights

Summary GBI Research’s latest report, Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceu ...

12-Oct-2018 $2995

PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets

By CBR Pharma Insights

PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets Summary GBI Research's latest report, PI3K Signaling Pathway Analys ...

01-Jul-2018 $2995

The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players

By CBR Pharma Insights

GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players, provides an in-depth assessment of the current trends in the global mid-size pharma market, a ...

04-May-2018 $2995

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018

By CBR Pharma Insights

GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views From Industry Survey 2018” considers the current and future impact of artificial intelligence (AI) technologies ...

30-Mar-2018 $2995

Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies

By CBR Pharma Insights

Summary Latest report, Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies, provides an in-depth assessment of the current trends in the global cosmeceu ...

01-Feb-2018 $2995

Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis

By CBR Pharma Insights

Summary “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” dis ...

01-Feb-2018 $2995